Surgical site infection with methicillin-resistant Staphylococcus aureus after primary total hip replacement.
Neogi
D S
DS
Yadav
C S
CS
Rastogi
S
S
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019644:Arthroplasty, Replacement, Hip; D003428:Cross Infection / Q000517:prevention & control; D006801:Humans; D008712:Methicillin / Q000627:therapeutic use; D055624:Methicillin-Resistant Staphylococcus aureus; D016459:Prosthesis-Related Infections / Q000188:drug therapy / Q000382:microbiology; D012293:Rifampin / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013530:Surgical Wound Infection / Q000188:drug therapy*; D014376:Tuberculosis / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D008712:Methicillin; D012293:Rifampin